Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in rats

Objective: To explore the effect of metoprolol on myocardial Apoptosis and caspase-9 activation after coronary microembolization (CME) in rats.

Methods: Forty rats were randomly divided into four groups (n=10 each): a sham operation (control) group, CME plus saline (CME) group, CME plus metoprolol (metoprolol) group and caspase-9 inhibitor Z-LEHD-FMK (ZLF) group. CME was induced by injecting 3000 polyethylene microspheres (42 μm diameter) into the left ventricle during a 10 s occlusion of the ascending aorta. Echocardiography, terminal deoxynucleotidyl transferase dUTP nick end labelling and Western blotting were used to evaluate cardiac function, Apoptosis and activation of caspase-9/Caspase-3, respectively, 6 h after CME.

Results: The echocardiographic parameters of left ventricular function were significantly decreased in the CME group compared with the control group (P<0.05); however, the metoprolol group and ZLF group showed significantly improved cardiac function compared with CME alone (P<0.05). Compared with the control group, the myocardial Apoptosis rate and the levels of activated caspase-9 and -3 increased significantly in the CME group (P<0.05). Again, these effects were ameliorated by metoprolol and ZLF (P<0.05).

Conclusions: The present study demonstrates that metoprolol and ZLF can protect the rat myocardium during CME by inhibiting Apoptosis and improving cardiac function, likely by inhibiting Apoptosis/ mitochondrial apoptotic pathway. These results suggest that antiapoptotic therapies may be useful in treating CME.